{"transactions":[{"id":4617419,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":18485,"kind":"person","name":"Dahl Andrew M.","position":1,"cik":"0002022347","reported_name":"Dahl Andrew M.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2026-09-14T22:04:01.000Z","date":"2026-09-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":253,"price":84.37,"value":21345.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e)."}],"balance_after":14615.41,"source":{"system":"sec-edgar","filing":"0001225208-26-007811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022347/000122520826007811/doc4.xml","form_type":"4"}},{"id":672276,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":18485,"kind":"person","name":"Dahl Andrew M.","position":1,"cik":"0002022347","reported_name":"Dahl Andrew M.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2026-08-31T21:47:55.000Z","date":"2026-08-31","kind":"sale","planned":false,"acquired":false,"shares":544,"price":91.055,"value":49533.92,"ownership":{"direct":true},"balance_after":14868.41,"source":{"system":"sec-edgar","filing":"0001225208-26-007408","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826007408/doc4.xml","form_type":"4"}},{"id":759256,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":18485,"kind":"person","name":"Dahl Andrew M.","position":1,"cik":"0002022347","reported_name":"Dahl Andrew M.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2026-05-29T20:44:17.000Z","date":"2026-05-29","kind":"sale","planned":false,"acquired":false,"shares":567.5266,"price":86.08,"value":48852.689728,"ownership":{"direct":true},"balance_after":15334.0948,"source":{"system":"sec-edgar","filing":"0001225208-26-005647","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005647/doc4.xml","form_type":"4"}},{"id":787473,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":18485,"kind":"person","name":"Dahl Andrew M.","position":1,"cik":"0002022347","reported_name":"Dahl Andrew M.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-05-09T01:16:30.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":6745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":6745,"derivative":{"exercise_price":82.76,"exercise_date":"2027-05-07","expiration_date":"2033-05-06","underlying":"Common Stock","underlying_shares":6745},"source":{"system":"sec-edgar","filing":"0001225208-26-005044","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005044/doc4.xml","form_type":"4"}},{"id":787472,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":18485,"kind":"person","name":"Dahl Andrew M.","position":1,"cik":"0002022347","reported_name":"Dahl Andrew M.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2026-05-09T01:16:30.000Z","date":"2026-05-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":289,"price":82.76,"value":23917.64,"ownership":{"direct":true},"balance_after":15901.6214,"source":{"system":"sec-edgar","filing":"0001225208-26-005044","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005044/doc4.xml","form_type":"4"}},{"id":787471,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":18485,"kind":"person","name":"Dahl Andrew M.","position":1,"cik":"0002022347","reported_name":"Dahl Andrew M.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2026-05-09T01:16:30.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":3020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":16190.6214,"source":{"system":"sec-edgar","filing":"0001225208-26-005044","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005044/doc4.xml","form_type":"4"}},{"id":787470,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":18485,"kind":"person","name":"Dahl Andrew M.","position":1,"cik":"0002022347","reported_name":"Dahl Andrew M.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2026-05-09T01:16:30.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":3985,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":13170.6214,"source":{"system":"sec-edgar","filing":"0001225208-26-005044","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005044/doc4.xml","form_type":"4"}},{"id":888928,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":18485,"kind":"person","name":"Dahl Andrew M.","position":1,"cik":"0002022347","reported_name":"Dahl Andrew M.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2026-02-23T22:08:49.000Z","date":"2026-02-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":176,"price":79.78,"value":14041.28,"ownership":{"direct":true},"balance_after":9089.4805,"source":{"system":"sec-edgar","filing":"0001225208-26-002408","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826002408/doc4.xml","form_type":"4"}},{"id":1000868,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":18485,"kind":"person","name":"Dahl Andrew M.","position":1,"cik":"0002022347","reported_name":"Dahl Andrew M.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2025-11-14T00:52:12.000Z","date":"2025-11-13","kind":"grant","planned":false,"acquired":true,"shares":1160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on November 13, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":9183.074,"source":{"system":"sec-edgar","filing":"0001225208-25-009137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009137/doc4.xml","form_type":"4"}},{"id":1040911,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":18485,"kind":"person","name":"Dahl Andrew M.","position":1,"cik":"0002022347","reported_name":"Dahl Andrew M.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2025-09-15T22:44:47.000Z","date":"2025-09-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":262,"price":77.57,"value":20323.34,"ownership":{"direct":true},"balance_after":7926.9331,"source":{"system":"sec-edgar","filing":"0001225208-25-007992","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825007992/doc4.xml","form_type":"4"}},{"id":1154320,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":18485,"kind":"person","name":"Dahl Andrew M.","position":1,"cik":"0002022347","reported_name":"Dahl Andrew M.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-05-09T23:34:17.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":5670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":5670,"derivative":{"exercise_price":74.63,"exercise_date":"2026-05-08","expiration_date":"2032-05-07","underlying":"Common Stock","underlying_shares":5670},"source":{"system":"sec-edgar","filing":"0001225208-25-004946","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004946/doc4.xml","form_type":"4"}},{"id":1154319,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":18485,"kind":"person","name":"Dahl Andrew M.","position":1,"cik":"0002022347","reported_name":"Dahl Andrew M.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2025-05-09T23:34:17.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":3335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":8106.5266,"source":{"system":"sec-edgar","filing":"0001225208-25-004946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004946/doc4.xml","form_type":"4"}},{"id":1250686,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":18485,"kind":"person","name":"Dahl Andrew M.","position":1,"cik":"0002022347","reported_name":"Dahl Andrew M.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2025-02-24T22:28:31.000Z","date":"2025-02-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":176,"price":73.3,"value":12900.8,"ownership":{"direct":true},"balance_after":4684.1255,"source":{"system":"sec-edgar","filing":"0001225208-25-002308","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825002308/doc4.xml","form_type":"4"}},{"id":1407018,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":18485,"kind":"person","name":"Dahl Andrew M.","position":1,"cik":"0002022347","reported_name":"Dahl Andrew M.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2024-09-16T21:25:57.000Z","date":"2024-09-13","kind":"grant","planned":false,"acquired":true,"shares":2920,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on September 13, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":4690.7834,"source":{"system":"sec-edgar","filing":"0001225208-24-008721","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824008721/doc4.xml","form_type":"4"}}]}